Cited by 33Cancer Risks and FactorsCancer, Lipids, and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases

Open access
Pellegata, Natalia S., Berriel Diaz, Mauricio, Rohm, Maria, Herzig, Stephan·2022·Cancer and Metastasis Reviews

Abstract

Obesity is an established risk factor for several human cancers. Given the association between excess body weight and cancer, the increasing rates of obesity worldwide are worrisome. A variety of obesity-related factors has been implicated in cancer initiation, progression, and response to therapy. These factors include circulating nutritional factors, hormones, and cytokines, causing hyperinsulinemia, inflammation, and adipose tissue dysfunction. The impact of these conditions on cancer development and progression has been the focus of extensive literature. In this review, we concentrate on processes that can link obesity and cancer, and which provide a novel perspective: extracellular matrix remodeling, angiogenesis, and adrenergic signaling. We describe molecular mechanisms involved in these processes, which represent putative targets for intervention. Liver, pancreas, and breast cancers were chosen as exemplary disease models. In view of the expanding epidemic of obesity, a better understanding of the tumorigenic process in obese individuals might lead to more effective treatments and preventive measures.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10555-022-10058-y

Cites

266 of 266 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity is associated with chronic low-grade inflammation and a plethora of metabolic dysfunctions such as insulin resistance, impaired glucose tolerance and hypertension.

    “Obesity is associated with chronic low-grade inflammation and a plethora of metabolic dysfunctions such as insulin resistance, impaired glucose tolerance and hypertension.”
  • Obesity increases the risk of developing secondary comorbidities, including type 2 diabetes, peripheral neuropathies, cardiovascular diseases, stroke and numerous cancer types.

    “Obesity increases the risk of developing secondary comorbidities, including type 2 diabetes, peripheral neuropathies, cardiovascular diseases, stroke and numerous cancer types12,13, underscoring the systemic effects of excess body fat and the need for holistic characterizations of the underlying structural and cellular changes.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S.
Affiliations
University Hospital Heidelberg (DE)
Corresponding author
Herzig, Stephan
Venue
Cancer and Metastasis Reviews
Published
2022-09
Volume
41
Issue
3
Pages
517-547
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
OpenAlex
W4294992477
Cited by
33
References
266
Citations by year
2026: 6 · 2025: 9 · 2024: 6 · 2023: 12
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • Cancer and Metastasis Reviews (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion, cc-by)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • Deutsche Krebshilfe (70115158)
  • H2020 European Research Council (949017)
  • Helmholtz Association (Initiative, Networking Fund)
  • European Foundation for the Study of Diabetes
  • Helmholtz Future Topic Aging and Metabolic Programming (AMPro, ZT-0026)
  • Else-Kröner-Fresenius-Stiftung (2020 EKSE.23)
  • Edith-Haberland-Wagner Stiftung
  • DFG (CRC/Transregio 205/2 314061271)
  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
obesity, cancer, extracellular matrix remodeling, angiogenesis, adrenergic signaling, obesity-related cancer risk, liver cancer, pancreatic cancer, breast cancer, inflammation, hyperinsulinemia, adipose tissue dysfunction, tumor progression
MeSH terms
Adipose Tissue, Extracellular Matrix, Humans, Neoplasms, Obesity, Adrenergic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review